Staging, growth properties and metastatic behaviour of a transplantable murine T-cell lymphoma.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  International journal of tissue reactions

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 6123481
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of in vivo cell distribution following either intraperitoneal or intravenous injection of lymphoid cells.

  1980cited by this paper
• Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen.

  1980cited by this paper
• Comparison of various forms of therapy in two different mouse tumor systems.

  1979cited by this paper
• Differences in the expression of histocompatibility antigens on mouse lymphocytes and tumor cells: immunochemical studies

  1979cited by this paper
• Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens *

  1979cited by this paper
• Entry of metastatic malignant cells into the circulation from a subcutaneously growing myelogenous tumor.

  1979cited by this paper
• The demonstration of acid alpha-naphthyl acetate esterase activity in human lymphocytes: usefulness as a T-cell marker.

  1978cited by this paper
• Mammary-carcinoma cells in mouse liver: infiltration of liver tissue and interaction with Kupffer cells.

  1978cited by this paper
• Cytochemical identification of T and B cells in situ in mouse lymphoid tissue and lymph nodes from the rat, gerbil and cat.

  1978cited by this paper
• Allograft cytotoxicity co-operation between alloimmune T cells and macrophages.

  1978cited by this paper
• Macrophage regulation of the T-cell allogeneic response during tumor growth.

  1978cited by this paper
• Invasion of lymphosarcoma cells into the perfused mouse liver.

  1977cited by this paper
• Immunogenetics of cell surface antigens of mouse leukemia.

  1977cited by this paper
• MOLECULAR RELATIONSHIP BETWEEN H‐2 AND ML ANTIGENS ON LEUKAEMIA L‐1210/v CELLS *

  1977cited by this paper
• Further evidence for depression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines.

  1976cited by this paper
• Continuous cultures of fused cells secreting antibody of predefined specificity

  1975cited by this paper
• Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells.

  1975cited by this paper
• Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor

  1975cited by this paper
• Macrophages in solid tumors. I. Immunologically specific effector cells.

  1974cited by this paper
• Characterization of the B-cell and T-cell regions of human lymphatic tissue through enzyme histochemical demonstration of ATPase and 5′-nucleotidase activities

  1974cited by this paper
• Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.

  1972cited by this paper
• Cytochemical identification of monocytes and granulocytes.

  1971cited by this paper
• THE CYTOLOGIC DEMONSTRATION OF β-GLUCURONIDASE EMPLOYING NAPHTHOL AS-BI GLUCURONIDE AND HEXAZONIUM PARAROSANILIN; A PRELIMINARY REPORT

  1964cited by this paper

• A Model of Chemotherapy-Induced Tumor Dormancy: Doxorubicin Retention and Degradation Defines Resumed Growth in Vivo

  2021cites this paper
• Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cells

  2005cites this paper
• Intratumoral low-dose interleukin-2 induces rejection of distant solid tumour

  2005cites this paper
• Mechanisms of tumour rejection in the murine DBA/2-SL2 concomitant immunity system

  2005cites this paper
• Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipients

  2004cites this paper
• Testing therapeutic potency of anticancer drugs in animal studies: a commentary.

  2002cites this paper
• Therapeutic efficacy of IL‐2‐loaded hydrogels in a mouse tumor model

  2002cites this paper
• Analgesics in mice used in cancer research: reduction of discomfort?

  1997cites this paper
• Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2).

  1997cites this paper
• Optimal regimes for local IL‐2 tumour therapy

  1996cites this paper
• Reevaluation of the Superiority of Polyethylene GlycolModified Interleukin-2 Over Regular Recombinant Interleukin-2

  1995cites this paper
• Vesicles for tumour-associated antigen presentation to induce protective immunity: preparation, characterization and enhancement of the immune response by immunomodulators

  1994cites this paper
• Effect of immunomodulators on specific tumor immunity induced by liposome‐encapsulated tumor‐associated antigens

  1994cites this paper
• Critical factors for liposome-incorporated tumour-associated antigens to induce protective tumour immunity to SL2 lymphoma cells in mice

  1993cites this paper
• Involvement of the omental lymphoid organ in the induction of peritoneal immunity against tumor cells.

  1993cites this paper
• Parathymic lymph nodes during growth and rejection of intraperitoneally inoculated tumor cells.

  1991cites this paper
• Immunotherapy of mice with a large burden of disseminated lymphoma with low-dose interleukin 2.

  1989cites this paper
• A novel approach to the generation and identification of experimental hepatic metastases in a murine model.

  1986cites this paper
• Concomitant immunization by the fully antigenic counterparts prevents modulated tumor cells from escaping cellular immune elimination.

  1986cites this paper
• Interactions between macrophages and T-lymphocytes: tumor sneaking through intrinsic to helper T cell dynamics.

  1986cites this paper
• Higher ADCC of murine peritoneal cells after immunization with allogenic tumor cells as compared with stimulation by adriamycin, BCG, and thioglycolate.

  1986cites this paper
• Implications of Macrophage T-Lymphocyte Interactions for Tumor Rejectability

  1986cites this paper
• Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model.

  1985cites this paper
• Functional activities of the NCTC 1469 macrophage-like cell line: comparison of the NCTC 1469 cell line with various other macrophage-like cell lines.

  1983cites this paper
• Acquisition of proviral DNA of mouse mammary tumor virus in thymic leukemia cells from GR mice

  1982cites this paper
• Cell surface antigen phenotypes and enzyme expression patterns of two murine T-cell lymphomas derived from early and/or mature thymus cells.

  1982cites this paper
• Eradication of Murine Lymphoma and Melanoma Cells by Chlorambucil‐Antibody Complexes

  1982cites this paper